Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical Update

Lexicon Pharma (LXRX) Tops Q2 EPS by 3c

July 30, 2021 7:08 AM EDT

Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $234 thousand, versus $9.16 million reported last year.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

... More